论文部分内容阅读
据统计,全球约有1亿6千万哮喘病患者,各国患病率约1％～5％不等。我国患病率接近1％,半数在12岁以前发病,成人男女患病率大致相同,约2％的患者有家庭史。哮喘临床上表现为反复发作性伴有哮鸣音的呼气性呼吸困难,胸闷或咳嗽,可自行缓解或治疗后恢复。若长期反复发作可导致气道重建,使气道增厚或狭窄,演变为阻塞性肺气肿。 哪些药物可以治疗哮喘? 治疗哮喘的药物很多,主要有以下几类: (1)抗过敏性炎症的药物: 主要有糖皮质激素类药物,如泼尼松(强的松)、氢化可的松、地塞米松、泼
According to statistics, there are about 160 million asthma patients in the world, with the prevalence rates ranging from 1% to 5% in various countries. The prevalence in China is close to 1%, with half of the cases occurring before the age of 12. The prevalence of both men and women in adults is about the same, with about 2% of patients having family history. Asthma clinically manifested as recurrent episodes of wheezing with breathless breathing difficulties, chest tightness or cough, relieve itself or after treatment recovery. If long-term recurrent can lead to airway reconstruction, airway thickening or stenosis, evolved into obstructive pulmonary emphysema. Which drugs can treat asthma? A lot of drugs for the treatment of asthma, mainly in the following categories: (1) anti-allergic inflammation drugs: the main glucocorticoid drugs such as prednisone (prednisone), hydrocortisone Dexamethasone, splashing